Skip to main content
Signal8

ASP Isotopes Inc. (ASPI) Form 10-Q — Nov 16, 2026

$ASPIForm 10-QFiled Nov 16, 2026, 4:44 PM ET0001193125-26-463698Original filing

ASP Isotopes filed its Q3 2026 10-Q showing revenue of $5.1 million for the quarter, up roughly 4x from $1.3 million a year ago, driven by the January 2026 acquisition of Renergen and growth in its specialist isotopes segment. Nine-month revenue reached $14.4 million versus $3.6 million in the prior-year period. The company still posted a Q3 net loss of $30.9 million (nine-month net loss of $72.0 million), with operating cash burn accelerating to $66.4 million for the nine months as it integrates Renergen and develops its nuclear fuels and helium/LNG segments.

Key figures

Revenue
14427000
Total Debt
Convertible notes payable at fair value of $85.9M, current debt $47.7M, noncurrent debt $5.3M
Revenue Yoy
+304% (nine months: $14.4M vs $3.6M)
Total Assets
538129000
Cash Position
201663000
Shares Outstanding
155834430
Q3 2025 revenue
1271000
Q3 2026 revenue
5124000
Share count yoy growth
111.7M to 155.8M shares outstanding since Dec 31, 2025
Gain on convertible note extinguishment
11250000

AI analysis

Red flags5 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    ASP Isotopes Inc. (ASPI) Form 10-Q — Nov 16, 2026: AI Analysis | Signal8